NeuroMetrix, Inc. (NURO)
NURO moved a median of -0.49% 30 minutes after news, and -0.63% by the close. How NURO actually reacts to news — the realized, point-in-time move the market made, measured across 158 labeled events over the last three years with zero look-ahead.
NURO’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 28% | 75 |
| 30-min | -0.49% | 29% | 102 |
| 60-min | -1.13% | 31% | 106 |
| to close | -0.63% | 38% | 110 |
| Middle 50% of NURO reactions | -1.69% to +0.24% |
|---|---|
| Median reaction (30-min) | -0.49% |
| Measured reactions | 158 |
Half of all NeuroMetrix, Inc. news events land between -1.69% and +0.24% at 30 minutes.
Reaction stats as of 2026-08-31. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when NURO moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to NURO's baseline. Nothing else.
Recent NURO events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 15-12G NeuroMetrix, Inc. | SEC filing · Form 15-12G | SEC EDGAR | — | — | |
| Form EFFECT NeuroMetrix, Inc. | SEC filing · Form EFFECT | SEC EDGAR | — | — | |
| Form 8-K NeuroMetrix, Inc. For: May 01 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form POS AM NeuroMetrix, Inc. | SEC filing · Form POS | SEC EDGAR | — | — | |
| Form S-8 POS NeuroMetrix, Inc. | SEC filing · Form S-8 | SEC EDGAR | — | — | |
| Form 10-K/A NeuroMetrix, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | +7.51% | |
| Form 10-K NeuroMetrix, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | +0.48% | |
| Form 8-K NeuroMetrix, Inc. For: Mar 21 | SEC filing · Form 8-K | SEC EDGAR | — | +0.23% | |
| Form DEFM14A NeuroMetrix, Inc. | SEC filing · Form DEFM14A | SEC EDGAR | +0.00% | -0.13% | |
| Form PREM14A NeuroMetrix, Inc. For: Jan 30 | SEC filing · Form PREM14A | SEC EDGAR | +0.00% | +1.41% | |
| Form 8-K NeuroMetrix, Inc. For: Jan 16 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +4.21% | |
| Form 8-K NeuroMetrix, Inc. For: Dec 27 | SEC filing · Form 8-K | SEC EDGAR | -1.02% | +1.28% | |
| Form 8-K NeuroMetrix, Inc. For: Dec 17 | SEC filing · Form 8-K | SEC EDGAR | -1.71% | -6.11% | |
| Form DEFA14A NeuroMetrix, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -1.71% | -6.11% | |
| NeuroMetrix to be Acquired by electroCore | Press release | GlobeNewswire | -1.71% | -6.11% | |
| NURO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NeuroMetrix, Inc. Is Fair to Shareholders | Press release | Business Wire | -1.71% | -6.11% | |
| Form 10-Q NeuroMetrix, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.84% | |
| Form 8-K NeuroMetrix, Inc. For: Nov 05 | SEC filing · Form 8-K | SEC EDGAR | +0.97% | -9.21% | |
| NeuroMetrix Reports Q3 2024 Business Highlights | Press release | GlobeNewswire | +0.97% | -9.21% | |
| NeuroMetrix Reiterates its Review of Strategic Alternatives | Press release | GlobeNewswire | +8.27% | +7.89% | |
| Form 10-Q NeuroMetrix, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -8.61% | |
| Form 8-K NeuroMetrix, Inc. For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.77% | |
| NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options | Press release | GlobeNewswire | +0.00% | -2.77% | |
| NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call | Press release | GlobeNewswire | — | +1.25% | |
| Form SD NeuroMetrix, Inc. | SEC filing · Form SD | SEC EDGAR | — | -0.52% | |
| Form 10-Q NeuroMetrix, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | -1.87% | |
| Form S-8 NeuroMetrix, Inc. | SEC filing · Form S-8 | SEC EDGAR | — | -1.87% | |
| NeuroMetrix Reports Q1 2024 Business Highlights | Press release | GlobeNewswire | +0.00% | +0.24% | |
| Form 8-K NeuroMetrix, Inc. For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | — | +5.44% | |
| Form 8-K NeuroMetrix, Inc. For: Apr 18 | SEC filing · Form 8-K | SEC EDGAR | +4.59% | +10.46% | |
| NeuroMetrix Announces Steps Taken to Enhance Shareholder Value | Press release | GlobeNewswire | +4.59% | +10.46% | |
| Form DEFA14A NeuroMetrix, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | — | -5.63% | |
| Form 8-K NeuroMetrix, Inc. For: Apr 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form DEF 14A NeuroMetrix, Inc. For: Mar 27 | SEC filing · Form DEF | SEC EDGAR | +0.00% | +1.43% | |
| NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy | Press release | GlobeNewswire | +1.04% | -2.56% | |
| NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia | Press release | GlobeNewswire | +0.52% | -0.51% | |
| Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired | Press release | Accesswire | -0.11% | +1.56% | |
| RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc. | Press release | Accesswire | — | +0.13% | |
| Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc. | Press release | Accesswire | -5.75% | -5.03% | |
| Form 10-K NeuroMetrix, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -5.75% | -5.03% | |
| Form 8-K NeuroMetrix, Inc. For: Feb 20 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +3.94% | |
| Form 8-K/A NeuroMetrix, Inc. For: Feb 20 | SEC filing · Form 8-K | SEC EDGAR | +2.29% | +8.65% | |
| Form 8-K NeuroMetrix, Inc. For: Feb 22 | SEC filing · Form 8-K | SEC EDGAR | -0.64% | -6.67% | |
| NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights | Press release | GlobeNewswire | -0.64% | -6.67% | |
| NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call | Press release | GlobeNewswire | +0.00% | +9.57% | |
| NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value | Press release | GlobeNewswire | -1.58% | -10.92% | |
| Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now | Press release | GlobeNewswire | -0.31% | -2.47% | |
| NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024 | Press release | GlobeNewswire | +0.00% | +1.19% | |
| NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID) | Press release | GlobeNewswire | -8.23% | +2.65% | |
| NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN) | Press release | GlobeNewswire | -0.16% | -2.12% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the NURO section they belong to.
Where else NURO is measured.
NURO earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Leap Therapeutics, Inc. (LPTX) | 158 | -0.37% | 43% |
| MEI Pharma, Inc. (MEIP) | 158 | +0.11% | 52% |
| MESOBLAST LTD ORD (MEOBF) | 157 | 0.00% | 5% |
| GOLD FINDER RES LTD (GLDFF) | 155 | +0.19% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is NeuroMetrix, Inc.'s median reaction calculated?
Every labeled NURO news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 158 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 29% of NURO's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-31.
Does NURO's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.